Goldman Sachs’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,859,760
| Closed | -$35.1M | – | 4465 |
|
|
2019
Q3 | $35.1M | Sell |
1,859,760
-1,989,634
| -52% | -$37.5M | 0.01% | 1195 |
|
|
2019
Q2 | $45.3M | Buy |
3,849,394
+560,119
| +17% | +$6.59M | 0.01% | 1068 |
|
|
2019
Q1 | $44.9M | Buy |
3,289,275
+527,103
| +19% | +$7.2M | 0.01% | 1094 |
|
|
2018
Q4 | $28.3M | Buy |
2,762,172
+1,572,396
| +132% | +$16.1M | 0.01% | 1316 |
|
|
2018
Q3 | $19.8M | Sell |
1,189,776
-117,744
| -9% | -$1.96M | 0.01% | 1658 |
|
|
2018
Q2 | $20.7M | Sell |
1,307,520
-387,567
| -23% | -$6.12M | 0.01% | 1597 |
|
|
2018
Q1 | $21.5M | Buy |
1,695,087
+33,090
| +2% | +$420K | 0.01% | 1535 |
|
|
2017
Q4 | $19M | Buy |
1,661,997
+145,503
| +10% | +$1.67M | ﹤0.01% | 1580 |
|
|
2017
Q3 | $18.6M | Buy |
1,516,494
+798,105
| +111% | +$9.78M | ﹤0.01% | 1626 |
|
|
2017
Q2 | $8.23M | Buy |
718,389
+49,304
| +7% | +$565K | ﹤0.01% | 2023 |
|
|
2017
Q1 | $13.9M | Buy |
669,085
+40,905
| +7% | +$851K | ﹤0.01% | 1693 |
|
|
2016
Q4 | $13.1M | Sell |
628,180
-77,027
| -11% | -$1.6M | ﹤0.01% | 1686 |
|
|
2016
Q3 | $23.1M | Sell |
705,207
-283,550
| -29% | -$9.29M | 0.01% | 1393 |
|
|
2016
Q2 | $24.7M | Buy |
988,757
+620,953
| +169% | +$15.5M | 0.01% | 1289 |
|
|
2016
Q1 | $9.01M | Sell |
367,804
-194,298
| -35% | -$4.76M | ﹤0.01% | 1785 |
|
|
2015
Q4 | $18.6M | Buy |
562,102
+181,076
| +48% | +$5.98M | 0.01% | 1374 |
|
|
2015
Q3 | $12.5M | Buy |
381,026
+63,653
| +20% | +$2.09M | ﹤0.01% | 1535 |
|
|
2015
Q2 | $16.8M | Sell |
317,373
-57,322
| -15% | -$3.04M | 0.01% | 1433 |
|
|
2015
Q1 | $10.8M | Buy |
374,695
+162,346
| +76% | +$4.69M | ﹤0.01% | 1631 |
|
|
2014
Q4 | $6.18M | Buy |
+212,349
| New | +$6.18M | ﹤0.01% | 1860 |
|